Table 2.
Long COVID symptoms self-reported by the participants in the 2022 assessments.
| Variables | Groups | |||
|---|---|---|---|---|
| Mild (n = 29) | Moderate (n = 32) | Severe/critical (n = 29) | Total (n = 90) | |
| Fatigue, n (%) | 19 (65.5) | 22 (68.8) | 18 (62.1) | 59 (65.6) |
| Small effort, n (%) | 7 (24.1) | 3 (9.4) | 3 (10.3) | 13 (14.4) |
| Moderate effort, n (%) | 6 (20.7) | 10 (31.3) | 6 (20.7) | 22 (24.4) |
| Greater effort, n (%) | 6 (20.7) | 9 (28.1) | 9 (31.0) | 24 (26.7) |
| Dyspnea, n (%) | 12 (41.4) | 12 (37.5) | 12 (41.4) | 36 (40.0) |
| Small effort, n (%) | 2 (6.9) | 1 (3.1) | 1 (3.4) | 4 (4.4) |
| Moderate effort, n (%) | 2 (6.9) | 6 (18.8) | 6 (20.7) | 14 (15.6) |
| Great effort, n (%) | 8 (27.6) | 5 (15.6) | 5 (17.2) | 18 (20.0) |
| Muscle pain, n (%) | 8 (27.6) | 10 (31.3) | 8 (27.6) | 26 (28.9) |
| Joint pain, n (%) | 10 (34.5) | 6 (18.8) | 10 (34.5) | 26 (28.9) |
| Headache, n (%) | 8 (27.6) | 9 (28.1) | 5 (17.2) | 22 (24.4) |
| Dizziness, n (%) | 9 (31.0) | 12 (37.5) | 9 (31.0) | 30 (33.3) |
| Tinnitus, n (%) | 6 (20.7) | 8 (25.0) | 10 (34.5) | 24 (26.7) |
| Sensation of hearing loss, n (%) | 7 (24.1) | 7 (21.9) | 5 (17.2) | 19 (21.1) |
| Otalgia, n (%) | 5 (17.2) | 5 (15.6) | 3 (10.3) | 13 (14.4) |
| Ageusia, n (%) | 5 (17.2) | 6 (18.8) | 5 (17.2) | 16 (17.8) |
| Anosmia, n (%) | 5 (17.2) | 4 (12.5) | 5 (17.2) | 14 (15.6) |
| Memory deficit, n (%) | 20 (69.0) | 22 (68.8) | 18 (62.1) | 60 (66.7) |
| Difficulty concentrating, n (%) | 17 (58.6) | 16 (50.0) | 13 (46.4) | 46 (51.7) |
| Capillary loss, n (%) | 7 (24.1) | 15 (46.9) | 9 (31.0) | 31 (34.4) |
Data are presented as absolute (n) and relative (%) frequency.